Table 4 Comparison of Clinical Data between Group A and Group B
From: Prevention and treatment of surgical site infection in HIV-infected patients
Parameters | Group A | Group B | t | P |
|---|---|---|---|---|
Preoperative | Â | Â | Â | Â |
 CD4 (cell/μ l) | 382.1 ± 184.1 | 382.0 ± 111.3 | −0.002 | 0.999 |
 CD8 (cell/μ l) | 609.4 ± 362.9 | 743.0 ± 318.9 | 0.717 | 0.487 |
 CD4/CD8 | 0.7476 ± 0.361 | 0.6012 ± 0.295 | −0.809 | 0.434 |
 WBC(x109/L) | 6.51 ± 2.79 | 4.72 ± 1.53 | −1.521 | 0.151 |
 Hemoglobin (g/L) | 123.7 ± 25.5 | 142.7 ± 31.1 | 1.344 | 0.200 |
 Platelet(x109/L) | 176.5 ± 120.1 | 267 ± 131.7 | 1.435 | 0.173 |
 Albumin (g/L)* | 39.9 ± 5.2 | 46.7 ± 1.3 | 3.792 | 0.004 |
Postoperative | Â | Â | Â | Â |
 CD4 (cell/μl) | 382.6 ± 186.1 | 388.4 ± 91.4 | 0.063 | 0.952 |
 CD8 (cell/μl) | 498.6 ± 67.3 | 723 ± 358.4 | 1.376 | 0.206 |
 CD4/CD8 | 0.766 ± 0.355 | 0.652 ± 0.329 | −0.527 | 0.613 |
 WBC(x109/L) | 7.895 ± 4.668 | 5.84 ± 1.92 | −1.143 | 0.281 |
 Hemoglobin (g/L)* | 103.4 ± 24.5 | 134.8 ± 27.2 | 2.354 | 0.035 |
 Platelet(x109/L) | 169.1 ± 48.5 | 226.3 ± 133.7 | 1.071 | 0.318 |
 Albumin (g/L) | 40.0 ± 5.5 | 43.9 ± 3.3 | 1.657 | 0.122 |